Dr. David Kirsch, Director of the Radiation Medicine Program, Head of the Department of Radiation Oncology, and Senior and Allan Slaight Scientist at UHN’s Princess Margaret Cancer Centre, has been elected to the National Academy of Medicine—one of the highest honours in health and medicine.
Dr. Kirsch was elected as a member for his contributions to advancing the understanding and treatment of sarcomas, a rare and complex group of bone and soft tissue cancers. His research has helped reveal how these tumours develop, spread, and respond to therapies—work that has directly influenced care for patients around the world.
Using sophisticated genetically engineered lab models and human sarcoma cell lines, Dr. Kirsch’s team studies the biological mechanisms of cancer and tests new therapeutic approaches. His research has informed international clinical trials that combine radiation therapy and immunotherapy to improve patient outcomes.
“It’s a privilege to work with such a talented and dedicated team of scientists and researchers, whose accomplishments are recognized by this award.” said Dr. Kirsch. “At UHN’s Princess Margaret Cancer Centre, we have an extraordinary environment where research, education, and patient care come together to advance cancer treatment and to make a difference for patients globally.”
Since joining UHN in 2023, Dr. Kirsch has strengthened the integration of discovery research with clinical care in radiation oncology. Supported by UHN’s collaborative research ecosystem and state-of-the-art infrastructure, his work continues to build bridges between laboratory discoveries and better outcomes for patients.
Peter and Shelagh Godsoe Chair in Radiation Medicine, Dr. Kirsch is recognized internationally as a leader in sarcoma research and clinical care. Over his career, he has mentored more than 60 trainees and received multiple awards for research excellence and mentorship.
The National Academy of Medicine elected 90 regular members and 10 international members this year, bringing its total membership to more than 2,500. Members are chosen by their peers for exceptional professional achievement and commitment to advancing health and medicine.
Dr. Kirsch’s election reflects not only his personal accomplishments, but also UHN’s global leadership in cancer research, innovation, and care.
Read the full announcement here.